Sulfonylurea vs pioglitazone: effects on endothelial function in type 2 diabetic patients

被引：0
|
作者：
Naka, K. [1 ]
Papathanassiou, K. [1 ]
Kazakos, N. [1 ]
Bechlioulis, A. [1 ]
Pappas, K. [1 ]
Makriyiannis, D. [2 ]
Liveris, K. [2 ]
Tsatsoulis, A. [2 ]
Michalis, L. K. [2 ]
机构：
[1] Univ Ioannina, Sch Med, Dept Cardiol, Michaelid Cardiac Ctr, GR-45110 Ioannina, Greece
[2] G Hatzikosta Gen Hosp, Dept Endocrinol, Ioannina, Greece
来源：
EUROPEAN HEART JOURNAL | 2007年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：466 / 466
页数：1
相关论文
共 50 条
  • [1] Effects of pioglitazone vs glyburide on endothelial function in type 2 diabetic patients with vascular complications: the SPLENDOR study
    Weir, D. L.
    McAlister, F. A.
    Senthilselvan, A.
    Dyck, J. R.
    Sandhu-Minhas, J. K.
    Eurich, D. T.
    DIABETOLOGIA, 2013, 56 : S392 - S393
  • [2] Effects of pioglitazone vs glyburide on endothelial function in type 2 diabetic patients with vascular complications: the SPLENDOR study
    Garofolo, M.
    Pucci, L.
    Lucchesi, D.
    Bruno, R.
    Russo, E.
    Bornez, V. Sancho
    Russo, R.
    Giusti, L.
    Dardano, A.
    Avogaro, A.
    Ghiadoni, L.
    Miccoli, R.
    Di Pietro, C.
    Penno, G.
    Del Prato, S.
    DIABETOLOGIA, 2013, 56 : S392 - S392
  • [3] Pioglitazone with sulfonylurea: glycemic and lipid effects in Taiwanese type 2 diabetic patients
    Tseng, CH
    Huang, TS
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 70 (02) : 193 - 194
  • [4] Pioglitazone vs glimepiride: Differential effects on vascular endothelial function in patients with type 2 diabetes
    Papathanassiou, Katerina
    Naka, Katerina K.
    Kazakos, Nikolaos
    Kanioglou, Chryssanthi
    Makriyiannis, Demetrios
    Pappas, Konstantinos
    Katsouras, Christos S.
    Liveris, Konstantinos
    Kolettis, Theofilos
    Tsatsoulis, Agathocles
    Michalis, Lampros K.
    ATHEROSCLEROSIS, 2009, 205 (01) : 221 - 226
  • [5] Effects of Pioglitazone on Endothelial Function in Type 2 Diabetic Patients With Vascular Complications: The SPLENDOR Study
    Penno, Giuseppe
    Pucci, Laura
    Lucchesi, Daniela
    Bruno, Rosamaria
    Russo, Eleonora
    Garofolo, Monia
    Bornez, Veronica Sancho
    Russo, Rossella
    De Kreutzenberg, Saula
    Miccoli, Roberto
    Avogaro, Angelo
    Ghiadoni, Lorenzo
    Di Pietro, Cinzia
    Del Prato, Stefano
    DIABETES, 2013, 62 : A129 - A129
  • [6] Effects of pioglitazone on endothelial function and aortic stiffness in patients with type 2 diabetes mellitus
    Watanabe, H
    Nakagawa, K
    Kakihana, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 469A - 469A
  • [7] Combination therapy with pioglitazone and sulfonylurea in patients with type 2 diabetes
    Schneider, R
    Egan, J
    Houser, V
    DIABETES, 1999, 48 : A106 - A106
  • [8] Effects of Pioglitazone on Endothelial Progenitor Cells in Type 2 Diabetic Patients With Vascular Complications: The SPLENDOR Study
    Del Prato, Stefano
    Lucchesi, Daniela
    Pucci, Laura
    Bruno, Rosamaria
    Russo, Eleonora
    Garofolo, Monia
    Fadini, Gianpaolo
    Bornez, Veronica Sancho
    Russo, Rossella
    Miccoli, Roberto
    Avogaro, Angelo
    Ghiadoni, Lorenzo
    Di Pietro, Cinzia
    Penno, Giuseppe
    DIABETES, 2013, 62 : A127 - A127
  • [9] Effects of pioglitazone versus metformin on endothelial function in patients with type 2 diabetes treated with sulfonylureas
    Naka, K. K.
    Papathanassiou, K.
    Bechlioulis, A.
    Pappas, K.
    Kazakos, N.
    Kanioglou, C.
    Vezyraki, P.
    Makriyiannis, D.
    Tsatsoulis, A.
    Michalis, L. K.
    EUROPEAN HEART JOURNAL, 2011, 32 : 65 - 66
  • [10] Effects of pioglitazone and metformin on vascular endothelial function in patients with type 2 diabetes treated with sulfonylureas
    Naka, Katerina K.
    Papathanassiou, Katerina
    Bechlioulis, Aris
    Pappas, Konstantinos
    Kazakos, Nikolaos
    Kanioglou, Chryssanthi
    Kostoula, Aggeliki
    Vezyraki, Patra
    Makriyiannis, Demetrios
    Tsatsoulis, Agathocles
    Michalis, Lampros K.
    DIABETES & VASCULAR DISEASE RESEARCH, 2012, 9 (01): : 52 - 58
12345